These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18269776)

  • 21. Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.
    O'Shaughnessy JA; Clark RS; Blum JL; Mennel RG; Snyder D; Ye Z; Liepa AM; Melemed AS; Yardley DA
    Clin Breast Cancer; 2005 Jun; 6(2):143-9. PubMed ID: 16001992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.
    Llombart-Cussac A; Martin M; Harbeck N; Anghel RM; Eniu AE; Verrill MW; Neven P; De Grève J; Melemed AS; Clark R; Simms L; Kaiser CJ; Ma D
    Clin Cancer Res; 2007 Jun; 13(12):3652-9. PubMed ID: 17575230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
    Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study.
    Köhler U; Olbricht SS; Fuechsel G; Kettner E; Richter B; Ridwelski K
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-40-S17-43. PubMed ID: 9374091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer.
    Dittrich C; Solska E; Manikhas A; Eniu A; Tjulandin S; Anghel R; Musib L; Frimodt-Moller B; Liu Y; Krejcy K; Láng I
    Cancer Invest; 2012 May; 30(4):309-16. PubMed ID: 22468806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
    Zhang CX; Huang S; Xu N; Fang JW; Shen P; Bao YH; Mou BH; Shi MG; Zhong XL; Xiong PJ
    Anticancer Drugs; 2007 Jun; 18(5):581-6. PubMed ID: 17414627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.
    Farhat FS; Temraz S; Kattan J; Ibrahim K; Bitar N; Haddad N; Jalloul R; Hatoum HA; Nsouli G; Shamseddine AI
    Clin Breast Cancer; 2011 Dec; 11(6):384-9. PubMed ID: 21993011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study.
    Ma CX; Steen P; Rowland KM; Niedringhaus RD; Fitch TR; Kugler JW; Hillman DW; Perez EA; Ingle JN; Adjei AA
    Ann Oncol; 2006 Feb; 17(2):226-31. PubMed ID: 16303865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II studies of pemetrexed in metastatic breast and gynecologic cancers.
    Smith I
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):63-5. PubMed ID: 15655940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.
    Chan S; Campone M; Santoro A; Conte PF; Bostnavaron M; Nguyen L
    Cancer Chemother Pharmacol; 2014 May; 73(5):903-10. PubMed ID: 24627219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of Loubo® (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes.
    Deng QQ; Huang XE; Ye LH; Lu YY; Liang Y; Xiang J
    Asian Pac J Cancer Prev; 2013; 14(1):413-7. PubMed ID: 23534764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer.
    Dent SF; Gertler S; Verma S; Segal R; Young V; Goel R; Keller O; Canil C; Iscoe N
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):557-61. PubMed ID: 19593565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer.
    Miles DW; Smith IE; Coleman RE; Calvert AH; Lind MJ
    Eur J Cancer; 2001 Jul; 37(11):1366-71. PubMed ID: 11435066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines.
    Martin M; Spielmann M; Namer M; duBois A; Unger C; Dodwell D; Vodvarka P; Lind M; Calvert H; Casado A; Zelek L; Lluch A; Carrasco E; Kayitalire L; Zielinski C
    Ann Oncol; 2003 Aug; 14(8):1246-52. PubMed ID: 12881387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer.
    Airoldi M; Cattel L; Pedani F; Marchionatti S; Tagini V; Bumma C; Recalenda V
    Breast Cancer Res Treat; 2001 Dec; 70(3):185-95. PubMed ID: 11804182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.
    Huang XE; Tian GY; Cao J; Xu X; Lu YY; Wu XY; Liu J; Shi L; Xiang J
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6663-7. PubMed ID: 24377585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer.
    Scinto AF; Cercato MC; Botti C; Tonachella R; Ferraresi V; Del Bianco S; Sacchi I; Cognetti F
    Eur J Cancer; 1994; 30A(9):1285-8. PubMed ID: 7999414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
    Hausmaninger H; Morack G; Heinrich B; Wallwiener D; Höffken K; Buksmaui S; Krejcy K; Miller MA; Possinger K
    Am J Clin Oncol; 2004 Aug; 27(4):429-35. PubMed ID: 15289740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors.
    Hanauske AR; Dumez H; Piccart M; Yilmaz E; Graefe T; Gil T; Simms L; Musib L; Awada A
    Invest New Drugs; 2009 Aug; 27(4):356-65. PubMed ID: 18956139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.